Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
作者信息
Bezzio Cristina, Saibeni Simone
机构信息
Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho (MI), Italy.
出版信息
Gastroenterology. 2021 Jun;160(7):2625-2626. doi: 10.1053/j.gastro.2020.05.082. Epub 2020 Jun 16.
Abstract
摘要
相似文献
1
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.重症炎症性肠病发作与2019冠状病毒病：扩充胃肠病学-外科学团队，纳入感染病专科医生。
Gastroenterology. 2021 Jun;160(7):2625-2626. doi: 10.1053/j.gastro.2020.05.082. Epub 2020 Jun 16.
2
Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.在新冠疫情期间管理炎症性肠病输液单元：服务调整与患者视角
Inflamm Bowel Dis. 2020 Sep 18;26(10):e125-e126. doi: 10.1093/ibd/izaa171.
3
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.COVID-19 大流行期间炎症性肠病患者的实用管理：澳大利亚胃肠病学会炎症性肠病学院专家评论。
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
4
Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19.中国广州一家胃肠病科在新冠疫情后恢复日常诊疗服务。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):645-646. doi: 10.1016/S2468-1253(20)30133-3. Epub 2020 May 4.
5
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.英夫利昔单抗或维多珠单抗用于炎症性肠病的维持治疗与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清阳性率增加无关：英国在2020年大流行中的经验
Gut. 2021 Dec;70(12):2398-2400. doi: 10.1136/gutjnl-2021-324116. Epub 2021 Feb 12.
6
The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable".2019冠状病毒病大流行时代的炎症性肠病管理：当“非紧急”并不意味着“可推迟”时。
Dig Liver Dis. 2020 Nov;52(11):1238-1240. doi: 10.1016/j.dld.2020.05.053. Epub 2020 Jun 18.
7
Low frequency of COVID-19 in inflammatory bowel diseases.炎症性肠病中新冠病毒病的低发病率
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
8
Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.炎症性肠病与新型冠状病毒肺炎大流行：更快行动，勿急行事。
Gastroenterology. 2021 Jan;160(1):473-474. doi: 10.1053/j.gastro.2020.05.013. Epub 2020 May 8.
9
Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
Psychosom Med. 2021 May 1;83(4):397-398. doi: 10.1097/PSY.0000000000000888.
10
Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".完善埃及的情况：对“新冠疫情期间埃及的炎症性肠病”的回应
Inflamm Bowel Dis. 2021 Mar 15;27(4):e39. doi: 10.1093/ibd/izaa355.
引用本文的文献
1
Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.成人 COVID-19 相关的自身免疫和风湿表现：一项更新的系统评价。
Front Immunol. 2021 Mar 12;12:645013. doi: 10.3389/fimmu.2021.645013. eCollection 2021.
2
Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.对患有 2019 年冠状病毒病的炎症性肠病患者的系统评价：是时候进行总结了。
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2689-2700. doi: 10.1016/j.cgh.2020.08.003. Epub 2020 Aug 7.
Zotero 插件